Researchers believe that the large increases in clinical ADHD diagnoses were unlikely to be representative of a real bump in prevalence.
These results may mitigate concerns by physicians regarding the pharmacological treatment of individuals with ADHD.
Antipsychotics have been shown to reduce tic severity, as has behavior therapy. However, the mechanisms behind the efficacy of behavior therapy have yet to be clarified by research.
Contrary to our expectation and the hypotheses put forward by Lulé et al., patients with ALS reported significantly lower rates of self-reported childhood ADHD, no difference in adult ADHD rates, and lower levels of attention deficit symptoms compared to the general population.
Medical costs for children with attention-deficit/hyperactivity disorder have consistently been determined to be higher than for those without the disorder, in part because of the frequency of comorbid conditions such as depression, anxiety, and substance abuse.
Investigators assessed cognition after long-term treatment with lisdexamfetamine dimesylate in children and adolescents with ADHD.
After a median of 25 years of follow-up, 2.4% of those born to a parent with a type 1 diabetes diagnosis were diagnosed with ADHD, compared with only 1.5% of the matched controls.
There is an increase in ADHD medication prescriptions in reproductive-aged women.
According to the FDA, Quillivant XR and ER are currently in shortage.
Weighing the benefits and risks of treatment options for ADHD in women of reproductive age is a clear priority.
These findings may raise new hypotheses for understanding the origins of ADHD, gender differences, and future targets in the prevention of ADHD.
Individual formulation-based CBT with usual treatment is more effective than usual treatment alone for improving core symptoms in ADHD.
Children whose fathers used SSRIs during the 3 months prior to conception were at an increased risk for ADHD compared with unexposed children.
A physician discusses their thoughts on the ADHD "epidemic."
ADHD in adults frequenly co-occurs with fibromyalgia syndrome, and FMS-related morbidity may be negatively impacted.
Cerebral morphometric alterations can differentiate between children with ADHD and controls.
Absolute increases in risks associated with stimulant use in women with ADHD are small.
There is a link between ADHD medication exposure during pregnancy and higher risk of neonatal morbidity.
In women with PsA, there is a higher prevalence of ADHD and depression.
In children with congenital hypothyroidism behavioral problems can be mitigated through appropriate levels of treatment during infancy.
There is an increased risk for ADHD in offspring born to mothers who used acetaminophen while pregnant.
Clinical differences may exist between the pharmacological and non-pharmacological treatments commonly used for the management of ADHD.
Children with confirmed ADHD who were not receiving medication for their disorder were randomly assigned to receive micronutrients or placebo.
Siblings with prenatal exposure to glucocorticoids were also compared with siblings with no exposure.
People with both bipolar disorder and ADHD have similar neurocognitive profiles compared with people with only bipolar disorder.
Many adolescents on ADHD medication skip or miss doses.
Results indicate there is an unmet need for better treatment to manage symptom burden in US adults with ADHD.
A chart outlining pharmacotherapies for ADHD, including information on form, strength, maximum dosages and administration.
Adolescents who had more severe ADHD symptoms as children were more likely to initiate smoking.
There does not appear to be a causal association between methylphenidate hydrochloride treatment for ADHD and suicide attempts.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Improving Performance of Everyday Activities Is Critical in Schizophrenia
- Analysis Finds Lithium Maintenance Most Effective as Monotherapy in Bipolar Disorder
- Web-Based Intervention Targets Parental Behaviors That May Affect Adolescent Anxiety, Depression
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Examining Associations Between Diabetes and Effects on Cognition
- Untreated Depression Common in Women of Childbearing Age
- Incidence of Psychiatric Disorders in Rheumatoid Arthritis
- Effect of Antidepressant Class, Dose on Pediatric Anxiety Disorders